We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
As per terms of the deal, Fresenius Medical Care will secure exclusive global rights to commercialize Humacyte’s Humacyl investigational human acellular vessel. Fresenius will take responsibility for the
The firm’s OCTA blood vessel measurement technology will assist clinicians in early detection and management of diseases causing progressive blindness. Optovue has also secured FDA approval for its
The company has secured funding under the financing round led by Kurma Partners. It headed the existing venture capital syndicate, including Paris-Saclay Seed Fund and Idinvest. Other historical
The acquisition will help Acelity to expand its advanced wound dressings portfolio, in addition to strengthening its presence in wound healing segment. Acelity president and CEO Andrew Eckert
The company carried out research on new Textray chest x-ray, which showed high rates of agreement between the algorithm and human radiologist experts. The chest x-ray AI analytics
ASP, which is a division of J&J’s Ethicon, provides advanced sterilization and disinfection solutions, as well as low-temperature hydrogen peroxide sterilization technology. Fortive president and CEO James Lico
Microbiotica is a microbiome-based therapeutics spun out of the Wellcome Sanger Institute, while Genentech is a member of the Roche Group. As part of the multi-year collaboration, Microbiotica
EPD is engaged in the development of innovative image-guided procedures for cardiac arrhythmias or heart rhythm disorders. The firm’s cardiac imaging and navigation system enables electrophysiologists navigate the
The company has secured series A financing under the round led by CincyTech, and participants include existing investors such as Mark Cuban’s Radical Investments and new investors such
The money was raised from new investor, Zhejiang Silk Road Fund and existing investors Escala Capital Investments, LGT, Cambridge Innovation Capital and Watrium. CMR Surgical will use the